Synthesis of (S)-1-(1H-indol-4-yloxy)-3[4-(3-methoxyphenyl)-4- hydroxypiperidin-1-yl]-propan-2-ol (LY333068) succinate, and its 3-[14C]- isotopomer based on chiral glycerol-[14C] derivatives

被引：0
|
作者：
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States [1 ]
机构：
来源：
J. Label. Compd. Radiopharm. | / 6卷 / 465-475期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Synthesis of (S)-1-(1H-indol-4-yloxy)-3-[4-(3-methoxyphenyl)-4-hydroxypiperidin-1-yl]-propan-2-ol (LY333068) succinate, and its 3-[14C]-isotopomer based on chiral glycerol-[14C] derivatives
    Czeskis, BA
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (06): : 465 - 475
  • [2] Synthesis of (S)-1-(1H-Indol-4-yloxy)-3-[4-(3- Methoxyphenyl)-4-Hydroxypiperidin-1-yl]- Propan-2-ol (LY333068) Succinate, and its 3-[14C]-Isotopomer based on Chiral Glycerol-[14C] Derivatives
    J Labelled Compd Radiopharm, 6 (465):
  • [3] Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs
    Bednarski, Marek
    Otto, Monika
    Dudek, Magdalena
    Kolaczkowski, Marcin
    Bucki, Adam
    Siwek, Agata
    Groszek, Grazyna
    Maziarz, Elzbieta
    Wilk, Piotr
    Sapa, Jacek
    ARCHIV DER PHARMAZIE, 2016, 349 (03) : 211 - 223
  • [4] Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1
    Groszek, Grazyna
    Bednarski, Marek
    Dybala, Malgorzata
    Filipek, Barbara
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) : 809 - 817
  • [5] Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2
    Groszek, Grazyna
    Nowak-Krol, Agnieszka
    Wdowik, Tomasz
    Swierczynski, Dariusz
    Bednarski, Marek
    Otto, Monika
    Walczak, Maria
    Filipek, Barbara
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (12) : 5103 - 5111
  • [6] Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers
    Bednarski, Marek
    Otto, Monika
    Dudek, Magdalena
    Siwek, Agata
    Zygmunt, Malgorzata
    Knutelska, Joanna
    Nowinski, Leszek
    Groszek, Grazyna
    Sapa, Jacek
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (01): : 81 - 87
  • [7] 1-(3,4- Dimethoxyphenyl)-3-(4-methoxyphenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
    Nacher-Luis, Anna
    Pastor, Isidro M.
    MOLBANK, 2024, 2024 (01)
  • [8] SYNTHESIS OF NEW 1-(AMINO)-3-[(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL) OXY] PROPAN-2-OL AND 1-[(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL) OXY]-3-(4-ARYLPIPERAZIN-1-YL) PROPAN-2-OL DERIVATIVES WITH AN EXPECTED β-ADRENOLYTIC ACTIVITY
    Kossakowski, Jerzy
    Struga, Marta
    Koziol, Anna E.
    ACTA POLONIAE PHARMACEUTICA, 2006, 63 (04): : 255 - 259
  • [9] SYNTHESIS OF 3-[4-(1-ETHOXYCARBONYL-1-METHYLETHOXY)PHENYL]-5-(3-PYRIDYL)-1,2,4-[3-C-14] OXADIAZOLE (AT-308-C-14
    HAYASHI, N
    TOGA, T
    MIYAKE, A
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1978, 14 (02): : 185 - 189
  • [10] SYNTHESIS OF 1-[2-HYDROXY-4-(3-SULFO-1-PROPYLOXY)-PHENYL]--3-(3-HYDROXY-4-METHOXYPHENYL)-PROPAN-1-ONE-1-C-14 SODIUM-SALT
    KOLTAI, E
    ESSESREITER, K
    BANFI, D
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1982, 19 (01): : 13 - 18
12345